National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 65168 [2019-25684]
Download as PDF
<![CDATA[
65168
Federal Register / Vol. 84, No. 228 / Tuesday, November 26, 2019 / Notices
Registration for Webinar: December 9,
2019, until 12:30 p.m. EST January 21,
2020.
Registration to view the webinar is
required.
ADDRESSES: Webinar web page https://
ntp.niehs.nih.gov/go/commprac-2020.
FOR FURTHER INFORMATION CONTACT: Dr.
Warren Casey, Director, NICEATM,
Division of NTP, NIEHS, P.O. Box
12233, K2–17, Research Triangle Park,
NC 27709. Phone: 984–287–3118, Email:
warren.casey@nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2021, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the
development and validation of toxicity
testing methods that protect human
health and the environment while
replacing, reducing, or refining animal
use. ICCVAM also provides guidance to
test method developers and facilitates
collaborations that promote the
development of new test methods. To
address these goals, ICCVAM will hold
a Communities of Practice webinar on
‘‘Use of Animal-free Affinity Reagents.’’
Affinity reagents such as antibodies
are used in a range of research,
diagnostic, and regulatory applications.
However, traditional methods for
producing such reagents require
immunization of laboratory animals.
Therefore, even when applied to
nonanimal test methods, their use is
inconsistent with the spirit of replacing,
reducing, or refining animal use. Use of
animal-based affinity reagents also
introduces variability into the methods
that use them.
This webinar will present a review of
the usefulness and limitations of
nonanimal-derived affinity reagents and
their potential to replace animal-derived
reagents. The preliminary agenda and
additional information about
presentations will be posted at https://
ntp.niehs.nih.gov/go/commprac-2020 as
available.
Webinar and Registration: This
webinar is open to the public with time
scheduled for questions by participants
following each presentation.
Registration for the webinar is required
and is open through 12:30 p.m. EST on
January 21, 2020. Registration is
available at https://ntp.niehs.nih.gov/
go/commprac-2020. Interested
individuals are encouraged to visit this
web page to stay abreast of the most
current webinar information. Registrants
will receive instructions on how to
access and participate in the webinar in
the email confirming their registration.
Individuals with disabilities who
need accommodation to participate in
this event should contact Elizabeth
VerDate Sep<11>2014
16:47 Nov 25, 2019
Jkt 250001
Maull at phone: (984) 287–3157 or
email: maull@niehs.nih.gov. TTY users
should contact the Federal TTY Relay
Service at (800) 877–8339. Requests
should be made at least five business
days in advance of the event.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 16 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that more
accurately assess the safety and hazards
of chemicals and products and replace,
reduce, or refine (enhance animal wellbeing and lessen or avoid pain and
distress) animal use.
The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) establishes
ICCVAM as a permanent interagency
committee of NIEHS and provides the
authority for ICCVAM involvement in
activities relevant to the development of
alternative test methods. Additional
information about ICCVAM can be
found at https://ntp.niehs.nih.gov/go/
iccvam.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts and publishes analyses
and evaluations of data from new,
revised, and alternative testing
approaches. NICEATM and ICCVAM
work collaboratively to evaluate new
and improved testing approaches
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about NICEATM can be
found at https://ntp.niehs.nih.gov/go/
niceatm.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: November 18, 2019.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HIV/AIDS Maternal,
Adolescent and Pediatric Therapeutics
Clinical Trials Network Leadership and
Operations Center (UM1—Clinical Trial
Required).
Date: December 18, 2019.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Roberta Binder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G21A, National Institute of Allergy
and Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5050,
rbinder@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 21, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–25684 Filed 11–25–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–25667 Filed 11–25–19; 8:45 am]
National Institutes of Health
BILLING CODE 4140–01–P
PO 00000
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
Frm 00056
Fmt 4703
Sfmt 4703
E:\FR\FM\26NON1.SGM
26NON1
]]>Agencies
[Federal Register Volume 84, Number 228 (Tuesday, November 26, 2019)]
[Notices]
[Page 65168]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25684]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; HIV/AIDS Maternal, Adolescent and
Pediatric Therapeutics Clinical Trials Network Leadership and
Operations Center (UM1--Clinical Trial Required).
Date: December 18, 2019.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Roberta Binder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G21A, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892-9823, (240) 669-5050,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 21, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25684 Filed 11-25-19; 8:45 am]
BILLING CODE 4140-01-P
